Pila Pharma AB (OSTO:PILA) Current Deferred Revenue : kr0.00 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pila Pharma AB Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Pila Pharma AB's current deferred revenue for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Pila Pharma AB Current Deferred Revenue Historical Data

The historical data trend for Pila Pharma AB's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pila Pharma AB Current Deferred Revenue Chart

Pila Pharma AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Deferred Revenue

Get a 7-Day Free Trial

Pila Pharma AB Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Current Deferred Revenue	Get a 7-Day Free Trial													-	-	-	-	-

Pila Pharma AB Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Pila Pharma AB's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pila Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pila Pharma AB (OSTO:PILA) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Norra Vallgatan 72, Malmo, SWE, 211 21

Website

https://www.pilapharma.com

Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.

Pila Pharma AB Headlines

No Headlines